Yahoo India Web Search

Search results

  1. Oct 21, 2021 · Thanks to a combination of blood tests, biometric data, and patient-provided information, the app allows healthcare providers to recommend various adjustments to diabetic patients. The level of precision seems to be able to control—and even reverse—type 2 diabetes.

  2. Mar 28, 2024 · This study proposes a novel approach that leverages digital twins and personal health knowledge graphs (PHKGs) to revolutionize diabetes care. Our key contribution lies in developing a real-time, patient-centric digital twin framework built on PHKGs.

    • 10.3390/jpm14040359
    • 2024/04
    • J Pers Med. 2024 Apr; 14(4): 359.
  3. Nov 15, 2021 · This study defines seven stages of diabetes reversal. The study is a retrospective pre/post comparison of changes in reversal stage, hemoglobin A1c (HbA1c), weight, body mass index (BMI), and other metrics measured before and after precision nutrition therapy.

    • Paramesh Shamanna, Shashank Joshi, Lisa Shah, Mala Dharmalingam, Banshi Saboo, Jahangir Mohammed, Ma...
    • 10.1186/s40842-021-00134-7
    • 2021
    • Clin Diabetes Endocrinol. 2021; 7: 21.
  4. Jul 20, 2023 · Digital twin (DT) is a relatively new approach that has emerged as a viable tool in several sectors of healthcare, and there have been some publications on DT in disease management. The systematic summary of the use of DTs and its potential applications in DM is less reported.

    • Yanting Chu, Shanhong Li, Jie Tang, Huiqun Wu
    • Front Med (Lausanne). 2023; 10: 1178912.
    • 10.3389/fmed.2023.1178912
    • 2023
  5. Jun 3, 2024 · The health digital twin to tackle cardiovascular disease—a review of an emerging interdisciplinary field. Article Open access 26 August 2022. Introduction.

  6. May 24, 2024 · We have developed a digital twin-based CKD identification and prediction model that leverages generalized metabolic fluxes (GMF) for patients with Type 2 Diabetes Mellitus (T2DM).

  7. People also ask

  8. Jun 4, 2022 · Researchers conducted a randomized controlled trial designed to determine the effect of Twin Precision Treatment technology (TPT) versus standard care (SC) on change in A1C and type 2 diabetes remission at 90-day intervals.